Familiar fixes for a modern malady: a discussion on the possible cures of COVID-19

Familiar fixes for a modern malady: a discussion on the possible cures of COVID-19

The SARS-CoV-2 virus emerged in December 2019 in Wuhan, China and then spread rapidly all over the world. Scientists are intensifying their research efforts in order to find antivirals specific to the virus and vaccines to treat or prevent COVID-19. Now, for a medicative cure for COVID-19, several d...

书目详细资料
主要作者:	Amrit Krishna Mitra
格式:	文件
语言:	English
出版:	AIMS Press 2020-12-01
丛编:	AIMS Molecular Science
主题:	covid-19 sars-cov-2 chloroquine hydroxychloroquine lopinavir ritonavir remdesivir favipiravir vitamin c convalescent plasma
在线阅读:	http://www.aimspress.com/article/10.3934/molsci.2020012?viewType=HTML

相似书籍

Review of Clinical Trials in COVID-19: Trying to Solve the Clinicians’ Conundrum
由: Amita Athavale, et al.
出版: (2020-07-01)

COVID-19: An Update about the Discovery Clinical Trial
由: Jean Jacques Vanden Eynde
出版: (2020-05-01)

Therapeutic Strategies in the Management of COVID-19
由: Rajashri R. Naik, et al.
出版: (2021-02-01)

A narrative review of antiviral drugs used for COVID-19 pharmacotherapy
由: Subodh Kumar, et al.
出版: (2021-01-01)

COVID-19: A Brief Overview of the Discovery Clinical Trial
由: Jean Jacques Vanden Eynde
出版: (2020-04-01)

A Comparative Study of Approved Drugs for SARS-CoV-2 by Molecular Docking
由: Achal Mishra, et al.
出版: (2021-06-01)

COVID-19 possible medical treatments
由: Marzieh Mohammadi, et al.
出版: (2021-01-01)

Current Clinical Trials and Vaccine Development Strategies for Corona Virus Disease (COVID-19)
由: Abhi Bhadra, et al.
出版: (2020-05-01)

Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review
由: Shahamah Jomah, et al.
出版: (2020-09-01)

Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis
由: Sultan Ayoub Meo, et al.
出版: (2020-10-01)

Comparison of effectiveness of various treatment strategies in COVID-19 patients: A Systematic Review
由: Muhammad Shehryar Hussain, et al.
出版: (2020-08-01)

Pharmacological management of COVID-19
由: Veena Raghunathan, et al.
出版: (2020-01-01)

An early assessment of the efficacy of medicines in the treatment of patients with COVID-19
由: A. S. Kolbin
出版: (2020-05-01)

Safety of Hydroxychloroquine, Favipiravir, and the Combination of Lopinavir and Ritonavir in the Treatment of the “First Wave” of the New Coronavirus Infection COVID-19
由: B. K. Romanov
出版: (2020-09-01)

Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines
由: Xinni Xu, et al.
出版: (2020-05-01)

The Rationale for Potential Pharmacotherapy of COVID-19
由: Maha Saber-Ayad, et al.
出版: (2020-05-01)

Effectiveness of Remdesivir, Lopinavir/Ritonavir, and Favipiravir for COVID-19 Treatment: A Systematic Review
由: Qomara WF, et al.
出版: (2021-11-01)

Drug Repurposing in the COVID-19 Era: Insights from Case Studies Showing Pharmaceutical Peculiarities
由: Milo Gatti, et al.
出版: (2021-02-01)

Characteristics and outcomes of acute respiratory distress syndrome related to COVID-19 in Belgian and French intensive care units according to antiviral strategies: the COVADIS multicentre observational study
由: David Grimaldi, et al.
出版: (2020-10-01)

COVID-19 treatment in children: A systematic review and meta-analysis
由: Prateek Kumar Panda, et al.
出版: (2021-01-01)

Repurposed pharmacological agents for the potential treatment of COVID-19: a literature review
由: Alina Kröker, et al.
出版: (2021-11-01)

Pharmacogenomics landscape of COVID-19 therapy response in Serbian population and comparison with worldwide populations
由: Stanković Biljana, et al.
出版: (2020-01-01)

Severe coronavirus disease 2019 (COVID‐19) pneumonia patients treated successfully with a combination of lopinavir/ritonavir plus favipiravir: Case series
由: Hayato Koba, et al.
出版: (2020-12-01)

Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications
由: Abubakar AR, et al.
出版: (2020-12-01)

Clinical evaluation of selected Pharmacological Treatments used for Coronavirus (COVID-19) pandemic
由: hasan mohammed altemimy
出版: (2020-06-01)

Efficacy of lopinavir/ritonavir plus interferon beta compared to hydroxychloroquine in the treatment of COVID-19: A retrospective observational study
由: Motahareh Amirizadeh, et al.
出版: (2023-01-01)

High Prevalence of Potential Drug-Drug Interactions Among Patients Treated with Off-label Therapies for COVID-19
由: Allan Ramos-Esquivel, et al.
出版: (2022-06-01)

Common anti-COVID-19 drugs and their anticipated interaction with anesthetic agents
由: Shagun B Shah, et al.
出版: (2021-01-01)

Progress in the Research and Development of Anti-COVID-19 Drugs
由: Lianzhou Huang, et al.
出版: (2020-07-01)

A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial
由: A. Abayomi, et al.
出版: (2021-12-01)

Measuring the energy for the molecular graphs of antiviral agents: Hydroxychloroquine, Chloroquine and Remdesivir
由: Muhammad Haroon Aftab, et al.
出版: (2024-01-01)

Evaluation of the efficacy and safety of favipiravir and interferon compared to lopinavir/ritonavir and interferon in moderately ill patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial
由: Mehdi Hassaniazad, et al.
出版: (2020-10-01)

Pharmacophore modelling of vanillin derivatives, favipiravir, chloroquine, hydroxychloroquine, monolaurin and tetrodotoxin as MPro inhibitors of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)
由: Woon Yi Law, et al.
出版: (2020-11-01)

The Effectiveness of Hydroxychloroquine Versus Hydroxychloroquine Plus Lopinavir/Ritonavir Therapy in SARSCoV- 2 Pneumonia
由: Ayşe BATIREL, et al.
出版: (2021-12-01)

Comparison of antiviral effect for mild-to-moderate COVID-19 cases between lopinavir/ritonavir versus hydroxychloroquine: A nationwide propensity score-matched cohort study
由: Min Joo Choi, et al.
出版: (2021-01-01)

The Australasian COVID-19 Trial (ASCOT) to assess clinical outcomes in hospitalised patients with SARS-CoV-2 infection (COVID-19) treated with lopinavir/ritonavir and/or hydroxychloroquine compared to standard of care: A structured summary of a study protocol for a randomised controlled trial
由: Justin T. Denholm, et al.
出版: (2020-07-01)

Antiviral activity of interferon-based combination therapy in critically ill patients with COVID-19: Preliminary observations
由: Paolo Gaibani, et al.
出版: (2021-03-01)

Cardiotoxic Drugs Used in the Treatment of COVID-19
由: A. S. Zmitrukevich, et al.
出版: (2024-01-01)

Determination of lopinavir/ritonavir concentrations in four different oral solutions for the application of antiretroviral therapy in very young, HIV-1-infected children
由: Nils von Hentig, et al.
出版: (2021-05-01)

Scoping insight on antiviral drugs against COVID-19
由: Ahmed S. Ali, et al.
出版: (2021-10-01)